Fatty acids enhance vascular alpha-adrenergic sensitivity

Area of Science:

• Cardiovascular Science
• Metabolic Research
• Vascular Physiology

Background:

• Obese hypertensive patients exhibit centralized body fat, risk factor clustering, and insulin resistance.
• Nonesterified fatty acids (NEFAs) are implicated in insulin resistance and may influence vascular tone.

Purpose of the Study:

• To investigate if NEFA abnormalities contribute to increased vascular alpha-adrenergic reactivity in obese hypertensive subjects.
• To assess the impact of elevated NEFA levels on vascular responses to adrenergic and angiotensin II stimulation.

Main Methods:

• Two protocols involving dorsal hand vein infusions of 10% Intralipid/heparin (to raise NEFAs) or control solutions (dextrose/heparin or saline/heparin).
• Assessment of hand vein sensitivity to phenylephrine (alpha-adrenergic agonist) and angiotensin II using a linear variable differential transformer technique.
• Studies conducted in normotensive subjects and normotensive African American women.

Main Results:

• Intralipid/heparin significantly reduced the dose of phenylephrine needed for 50% maximal venoconstriction compared to controls (P < .01).
• Elevated NEFA levels increased vascular sensitivity to phenylephrine but did not significantly alter responses to angiotensin II.
• Findings suggest NEFAs play a role in alpha-adrenergic mediated venoconstriction.

Conclusions:

• Abnormalities in nonesterified fatty acids may contribute to increased neurovascular tone in obese hypertensive individuals.
• Targeting NEFA metabolism could be a potential strategy for managing hypertension and associated vascular dysfunction.